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Hvpothesis:
The A-MybRepro9 male mutant is sterile because of a mutation on transcription
factor A-Myb. This mutation changes the transcriptional function of A-myb, which
causes differential expression of genes that are fundamental to the processes of meiosis
and spennatogenesis.
Si2nificance of Project:
This project aims to understand the role of the transcription factor A-myb and its
targets in spermatogenesis. If the project is successful, we will know how a mutation in
the MybLl gene leads to male sterility in the mouse. This information will give us a
more detailed picture of the processes of meiosis and spermatogenesis, not just in the
mouse but in all organisms with homologous genes and mechanisms.
Ultimately, knowledge of the inner workings of meiosis and spermatogenesis will
allow for advances in human and veterinary medicine. A knowledge of which genes and
proteins playa major role in spermatogenesis may allow doctors to reverse sterility in
humans, and may help couples who cannot conceive children at the moment to be able to
in the future. For example, if a mutation in MybLl is causing male mice to be sterile
because of an affected downstream gene, then researchers will be able to devise a simple
genetic test for male sterility that will look for mutations in either of these two genes.
Males with mutations in these genes may one day be prescribed a drug that will "cure"
them by giving them the exact protein that they are unable to produce.
Another potential application of this knowledge is new forms of birth control. If
this research finds that a gene product specific to spermatogenesis the cause of male
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sterility in mice, then this product could be blocked or degraded using a drug. In this
way, males could be temporarily sterilized with a male version of the birth control pill.
Finally, because the Myb class of proteins is expressed in tissues other than the
testis, our research may facilitate research in other areas. Our understanding of the way
MybLl affects spemlatogenesis has the potential to unlock the functions of the Myb cl~s
of proteins in breast tissue, among others.
Theorv:
SDermatogenesis:
Spennatogenesis functions to produce haploid gametes, allowing sexual
reproduction to occur. These haploid gametes, sperm, are produced in the testes. When
the sperm fuse with the haploid gametes produced in the ovaries (the ovum), they
produce a single-celled organism called a zygote, which eventually grows into a multi-
cellular organism of the same species as the parents.
Spermatogenesis forms spenn cells by an elaborate differentiation process that
includes meiosis, which is a special type of nuclear division that segregates one copy of
each homologous chromosome from the diploid progenitor into each new "gamete."
Meiosis, unlike mitosis, reduces the number of sets of chromosomes by half, so that when
gametic recombination (fertilization) occurs, the ploidy of the parents Will be
reestablished (Alberts, 2002).
At early stages in meiosis, homologs become coaligned along their lengths; the
fornlation of meiosis-specific double-strand breaks (DSBs), which initiates genetic
recombination, drives this pairing. At intermediate stages, the coaligned homolog axes
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become intimately connected via a prominent zipper-like structure, the synaptonemal
complex (SC); at about this same time, some or all DSBs are converted to double
Holliday junctions, and recombination begins. At the next stage of meiotic prophase, the
pachytene phase, SCs occur along the entire lengths of all homolog axes. The
recombination process is completed at about the end of the pachytene phase; mature
crossover and noncrossover ecombination products both occur at about this time. At
pachytene, chromatin loops are tightly condensed. Exit from pachytene is signaled by the
disassembly of SCs and the reorganization of the chromosome structure in preparation for
the first nuclear division. In organisms with large chromosomes, dramatic compaction
can occur at this stage. During the next stage, diplotene, the SC degrades and
homologous chromosomes begin to separate. The transition from pachytene to metaphase
I is an important point for regulation of meiotic development in many organisms (Xu,
1995).
This process requires that homologous chromosomes pair, synapse, and
recombine. In many organisms including mammals, mutations that disrupt pairing,
synapsis, and/or homologous recombination confer a meiotic arrest phenotype resulting
in sterility. Experiments with Saccharomyces cerevisiae (yeast) have shown that many
recombination checkpoints exist during meiosis (Reinholdt and Schimenti, 2005).
Meiotic cells monitor the progression of chromosome metabolism and arrest at pachytene
in response to certain critical defects (Xu, 1995).
However, of all the genes required for the induction and initial processing of
meiotic DSBs in yeast, only three are present in mammals (Keeney 2001). Therefore, it is
likely that the majority of mammalian genes required for initiation of meiotic
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recombination remain to be identified (Reinholdt and Schimenti, 2005). Similarly, very
little is known about transcription during spermatogenesis, o research in this area is very
important.
Mutae:enesis:
Mutations are the basic tools of genetic analysis: altering genes one at a time by
inducing mutations allows us to see what functions each gene has. This can be done in
mice by simply breeding and waiting for mutations to occur, but this process is extremely
slow. The effectiveness of the hunt can be improved dramatically by using mutagens that
will induce mutations and allow for faster identification of mutations that cause the
desired phenotype. A major problem with chemically-induced and irradiation-induced
mutations, however, is that they are generated essentially at random. In order to identify a
mutant phenotype of interest, a laborious screen for mutants needs to be conducted by
close examination of the phenotypes following mutagenesis (Alberts, 2002).
Weare using forward genetic screens to find new autosomal recessive mutations
affecting meiotic recombination in mammals (Reinholdt and Schimenti, 2005). A genetic
screen is a procedure that is used to identify individuals with a phenotype of interest. In a
forward genetic screen, mice that exhibit a mutant phenotype (sterility, in our case) are
selected in order to find genes that are causing this phenotype.
One such recessive mouse mutant, the Repro9 mutant, encounters problems
during the meiosis stage of spemlatogenesis, when homologous chromosomes nomlally
align and recombine before the spermatocytes divide and eventually differentiate into
spenn. The Repro9 mutant has a mutated allele at the locus that produces the
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transcription factor A-Myb. This project aims to elucidate the functions of this key
transcription factor in spermatogenesis.
Mvb Class of Genes:
A-Myb is one of a class of Myb genes, all of which are very similar structurally.
The Myb proteins are not limited to expression within the testis or in cancerous cells. B-
Myb is expressed in all dividing cells, and c-Myb and A-Myb are often co-expressed. In
addition to homologous structure, all three proteins (A-, B-, and C-Myb) bind the same
DNA sequence in vitro and all activate the same reporter gene constructs in transient
transfection assays, suggesting that they should have similar activities on endogenous
genes (Rushton, 2003). However, several studies have found that this is not the case.
Over expression of each version of Myb in the MFC7 cell type, for example, has a unique
activity and leads to the activation of a different set of endogenous genes. This implies
that the Myb proteins differ not by their relative strengths as transcriptional activators but
in some qualitative feature, such as relative access to promoters or in ability to interact
with cofactors (Ness, 2003). The expression patterns ofMyb in testis have not been
studied in depth.
We know that an alternate version of the transcription factor A-Myb that results
from a point mutation is expressed in the Repro9 mutant. In studying which genes'
transcription is directly and indirectly affec~ we can learn about the functions of these
genes and of A-Myb. This will allow us to increase our knowledge of transcription and
the role of genes and transcription factors in spennatogenesis, and potentially meiosis in
general.
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Histones:
Histones are the proteins that act as spools around which DNA winds in the
nucleus of the cell. They enable the large genomes of eukaryotes to fit inside a cell: the
compacted molecule is 50,000 times shorter than an unpacked molecule. Combinations
of histone modifications are thought to constitute a code, the so-called "histone code,"
which determines which DNA is wound or unwound so that transcription can occur.
Histone modifications act in diverse biological processes uch as gene regulation, DNA
repair and chromosome condensation (mitosis) (Alberts, 2002).
Characterization of the meiotic defects in the homozygous Repro9 mutant males
indicated aberrant staining of DNA repair foci, indicating possible defects in chromatin
organization. Many core histone replacements and modifications occur during mouse
spermatogenesis (Lewis, 2003). We thus used immunohistochemical staining of
testicular cross-sections to look for potential differences in the histone code that may
have produced the effects seen in the mutant. We examined a subset of known histone
modifications using innumohistochemical staining of wild-type and mutant testis. This
allowed us to identify yet more differences between our Repro9 mutant and the wild-type
testes.
Earlier Work:
In order to identify genes that playa role in spennatogenesis, we used a forward
genetic screen, a process in which affected phenotypes are used to identify new genes.
Mice were mutated using the chemical N-ethyl-N-nitrosourea (ENU). Mutant pedigrees
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were screened for infertility, and the Repro9 mutation was discovered. Repro9 was
found to cause male-specific infertility.
Male sterility indicates a problem with spermatogenesis, and so the testes of the
mutant male mice were studied in further detail to find the effects of the newly
discovered mutation. First, an overall comparison in body size, weight, testes size, and
other factors was performed to learn about the major effects of this mutation. Next,
cross-sections of the testes were prepared. We used microscopy to look at these cross-
sections. Spennatocytes were immuno-labeled using antibodies directed against axial and
central elements of the synaptonemal complex so that problems with synapsis and other
meiotic defectS could be identified.
Recombination mapping was used to define the critical region harboring the gene
of interest. This method involved mating mice heterozygous for the mutation and
screening recombinant male progeny for sterility. If a mouse was a product of
recombination in one region of its chromosome but still had the sterile phenotype, then
that region was ruled out as a potential location for the mutation. Recombination events
were used to narrow the location of the mutation down to a small region, a centromere-
proximal 7Mb region on chromosome 1. Genes within this critical region were
considered as potential candidates in causing the observed phenotype.
The MybLl gene was found and sequenced in order to find the mutation. Once
the knockout mouse was available to us., complementation analysis was used to tell
whether the Repro9 mutation was indeed in the MybLl gene. This analysis depends on
1 The mouse was not available earlier in our lab because another lab, which had been studying the A-Myb
expression in breast tissue, had already developed a knockout mouse (a mouse with that gene inactivated).
Because it is extremely tedious to create a knockout &om scratch, our lab requested that an A-Myb
knockout mouse be sent to us. See the section entitled "Mighty Mouse" below for a discussion of the
sharing of mice between labs.
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the phenomenon of genetic complementatio~ that is, the restoration of the wild-type
phenotype by mating of two different mutants. If two recessive Inutations, A and B, are in
the same gene, then a diploid organism heterozygous for both mutations will exhibit the
mutant phenotype. However, if mutation A and B are in separate genes, then
heterozygotes carrying a single copy of each mutant allele will exhibit the wild-type
(normal) phenotype. In this case, the mutations are said to complement each other.
(Lodish, 2000).
Once the affected gene product had been identified as a transcription factor, A-
Myb, we became interested in the targets of its transcription.
Methods:
Microarravs:
In order to see which genes are affected by the mutation, microarrays were
performed. Microarrays measure the expression of mRNA (the intermediate between
DNA in the nucleus and the translated protein that is the eventual product). The mRNA
expression is a good measure of how much a certain gene is transcribed, with the caveat
that certain mRNA is degraded more quickly than other mRNA. IStill, relative expression
of the same mRNA gives a good measure of how much a certain gene is transcribed.
Microarray analysis was performed on RNA obtained from ground-up testes
tissue of both wild-type and mutant mice, both in 17 -day post conception (dpc) and 14-
dpc mice. The genes that were differentially expressed by two-fold or more in the wild
type versus the mutant were noted.
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The results of the microarray were in spreadsheet form with no way to sort results
by gene function or location, though this information is included in the data set. These
results were transformed into a list that could be sorted by gene function and location.
This infornlation was used to group the genes that were of interest to us.
This list of genes was reduced in two ways. The genes we considered had a Log2
value above 1 or below -1, meaning there was a two-fold difference in expression
between wild-type and mutant. In addition, because the Schimenti lab has microarray
expression data on various other meiotic mutants that exhibit male sterility, the A-Myb
data were compared against these other mutants. Those genes that were similarly
differentially expressed in other mutants were removed from the list as well since they
were not specific to the mutation and are likely affected due to the similarity in arrest
point of these mutants rather than A-Myb regulation and not necessarily a direct by-
product of our mutation. We will fe-visit these genes once we have studied the others.
Verification:
The final list of potentially regulated genes needed to be verified. Primers, which
are strands of DNA that serve as a starting point for DNA replication, were created for
each of the genes using Alleleill 3 software. This was done so that each gene could be
amplified in a Polymerase Chain Reaction (PCR) in order for genetic expression to be
measured. The list of primers is as follows:
Gene Sense Primer Antisense Primer
RIKEN cDNA 1700029101 gene TTAGCGATGTGATACTTGAAGCC TCCCTGATTGAGACTAACGGTAG
RIKEN cDNA 4930428801 gene GGGTACTCATGTTCAACTGTG A TGCCTTGCTTTCA TCCC
RIKEN cDNA 4930515G13 gene AGGGATAAGAGGTTCACGAG TTGCTGGCGAGATGGTAG
PHD finger protein 7 TTGTGTCAACGACT MAG GGTAACAGTCAGAAGAGG
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GACAATCTCGTGGCAATC T AGGCTT A TTCTTGACTTGAGRIKEN cDNA 4933401119 gene
RIKEN cDNA 1700047116 gene TCGTGTCAACATTCCAAG TGAACCACTCCTAAAGGG
R/KEN cDNA 4930524815 gene GGAGCAAAGTACAGCMGTC ACCCAGGAAGGTGTCAGG
RlKEN cDNA 4930503816 gene TTGCCTGTGTCGTTGCTG GAA TGCTTGGAGTCTTGAGA T AG
RIKEN cDNA 4930542C12 gene TCACAGGTCAACCATCCATCAAAC CCAGGCAGGAGAATTAAGGCTATC
centromere protein P GCCTGCT AGGTGT ACTTGG AAAGAGAAATGCTCATAGTCAAC
cyclin N-tem\inal domain
AGTCACTACAGTTCACCAGcontaining 1 GAGAAAGGGAAGGAAGAA TC
flbronectin type 3 and ankyrin
repeat domains
RIKEN cDNA 1700001LO5 gene
metallothioneln-llke 5, testls-
GCGTC m ~ TCTTTGTCCGCCA TTGCTCTGTGA TTGAC
TCTGGCTTCCTGGTCCTGT AGCA TCAGTTGCTTGGAGTCACA TAG
GGGA TGA TGGGAACTTGCspecific (teamln) CGTGTT A TCGTCGTT ACTTC
ATAGGCAAAGGmCAAAGGGTGAGGACAAAATAGAGTGG
CCCTGAGAGTCCAAGATTC CTCCTGTGACA TCCGMC
ropportn 1-1lke
solute carrier family 2
CAGA TGTTTCACCAACTCTCCT ACsorbitol dehydrogenase TGCGGCTCAGATGTTCACTAC
TCAAGGCAGTCAAGGCTATGG TGTCCCTGGTT A TTGT A TGA TTGCTAF15 RNA polymerase II
RJKEN cDNA 17001 08N07 gene OM TCm AAGGGCGAA TCTG CTCCA TTGTCCTCTTCTTCC
C2 and coIled<oil domain
CCAGGACGCACTCAGGAC TCA m AACCGCACA T A TTCA TCGcontaining 2
RIKEN cDNA 1700110101 gene CCATAGGAGCCATCAAGCAAG CTAAGCCTGGTGGTGTAAGC
Beta Actin CGTGCGTGACATCAAAGAG TGCCACAGGATTCCATACC
bromodomaln, testls-speclflc
Cancer/testJs antigen 3
TT AAGCGGCAAGAGA TTC GTGGT AGGAGTTGTTGTG
CCTCTCAAGACTTCTCCT ACTCAG A TCACCT AACAAACTGCCTTCTG
AGTGAATCCAGATACACCAGAA GCTGTTCCACTGTATAGACATCAA
RlKEN cDNA 4930528F23 gene GCCAATATCCTAC CTATTGTGmAAG
RIKEN cDNA 4932415G12 gene A TTGCCAAGT AACTGCTTCTCAC ACCCAAAGTCAACCTCTGTCC
RIKEN cDNA 4930418G15 gene AGTCACTAACCTGAATTACACCAC TTCTTCT AA TCCTTCCAAGCCTTC
CCCTCGCCTGGACCmG
ACT ACTGGTGGCTTGGACAA TGC
CTAGAGAAACTGGGTTCACATTAC
CCGAA TGTTCACACGAAAGGAGAC
H2A histone family, member X
hematopoietic cell transcript 1
GCGATGATAGCATAGTTCmCC GGCA T A TCTCCACTTCCTTCCRIKEN cDNA 1700027M21 gene
RIKEN cDNA 1700016M24 gene GGTGGTCAATAAGATCAAGAAC GAGGTGGAAGAAGAAAGCC
lublquitin-conjugating enzyme
E2T GAGGTCACGGAGAGTCTG GCATGATCTCAAGTGAAAGG
RJKEN cDNA 4930521A18 gene TGGAAGCAAAGAGCAAGGAAGG TCGGGATTGAGGAGACTGGATAG
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homebrew SYBR green mix. One of the articles referred me to usenet and Yahoo!
Groups, both of which are online resources where researchers can swap recipes and ask
each other questions (Bustin, 2002). used these resources to detennine which
components were necessary and to get a sense of what concentrations were permissible.
I used a journal article to learn about how each component in my mix would
affect the sensitivity of my qPCR reaction. This paper scientifically tested how different
dilutions of SYBR green and different substances in which the SYBR could be diluted
affected the outcome of a reaction (Karsai, 2002). However, I needed a measurement of
background fluorescence, and the article did not discuss this at all. Thus, I used the
online resources to find people who had used 6-RO~ which is the background
fluorescence component hat is included in the commercial SYBR Green mix.
In my next step, I compared the efficiency of my homebrew mix to that of the
commercial Applied Biosystems mix. This ensured that my mixture worked similarly to
the commercially available mix I was trying to emulate. I set up equivalent reactions
using both mixes on one 96-well qPCR plate, so that both mixes would be tested on the
same primer sets and under the same exact conditions.
The online resources I used do not go into as much detail as journal articles with
regard to which components to use and in what amount. Thus, when I finally ran the
commercial mix against my homebrew, the fluorescence was much lower in the
homebrew mix (on the order of to-fold). I found the same results both in repeated testing
with the same primers and with other primer sets, thus confinning that it was not user
error or a primer-dependent problem. I ran the same three primer sets and the same
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cDNA with both my homebrew and the commercial mix to test the efficiency of my new
reagents.
When I looked back into the resulting graphs and charts in the software, I was
shocked to find that the true fluorescence of SYBR Green in each mix was almost the
same (see Figure 1). The problem was that the fluorescence of my baseline reading, the
6-ROX, was entirely too high. Since the software was comparing the SYBR green level
against the fluorescence of 6-ROX, the result was a very low fluorescence. Thus, I
needed to decrease the level of 6-ROX in the mix.
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previously tried to increase the fluorescence of my mix by boosting the SYBR green 10-
fold, with almost no results. This happened for two reasons. F~ SYBR green inhibits
PCR reactions when it is present at high levels (Karsai. 2002). Second, the level of
fluorescence of SYBR green was increasing, but I could not see this because the baseline
of the 6-ROX was just too high. The raw fluorescence data showed me that the lO-fold
increase in SYBR boosted its raw fluorescence about 2/3 as much as I needed to decrease
the ROX. Thus, I presumed that a IS-fold dilution of the 6-ROX would be necessary to
get similar readings to a commercial mix.
The final mixture was as follows:
2X homemade SYBR 2feen ~remix: Makes 5mL. thus 400 reactions at IX
1000 uII OX PCR Gold buffer (ours has 15mM MgC12)
2035 uI H2O
1000 uIIOmM MgC12 (because we have the 15mM in the buffer)
80 uI 25mM dNTPs
25 uII: 100 diln SYBR Green I nucleic acid gel stain (in DMSO)
1 uIl ug/uI 6-ROX (in DMSO)
800 uI DMSO
50 uI 5U/uI AmpliTaq Gold
(Sui Tween 20)
Identifying A-Myb Binding Sites:
It is important to see which of the genes being studied have in silico evidence of
A-Myb binding sites in their promoters, since only these genes can be directly regulated
by this transcription factor. Transcription factors bind to particular sequences which are
usually unique to one or a few factors. The sequence of the binding site for A-Myb is
known to be AAC(Gfr)G(G/C)C, with letters in parenthesis representing "wobble" sites
that can be either of the two bases. Online software called MATInspe ctor
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(http://www .genomatix.de/online_help/help _matinspector/matinspector_help.html) was
used to identify potential Myb binding sites in the promoters (lkb upstream region) of
each prospective gene. The gene sequenCes were found at the Mouse Genome
Informatics (MOl) website site.
Because the sequence is a short degenerate consensus ite, we expect the site to be
found relatively frequently. We should expect to find a non-degenerate 7-mer
approximately every 1 ~r 16 kb in random sequence. The frequency increases as we add
'wobble' sites to approximately every 1 per 4 kb. In addition, the sequence is not specific
for A-Myb because B-Myb and C-Myb bind the same promoter sequences.
Immunohistochemistrv for Stainin£! Histones:
Testes from 21 day juvenile wild type and mutant males were fixed in Bouin's
Solution,and paraffin-embedded. Four micron sections were placed on polylysine-coated
microscope slides. Slides were deparaffinized by washing in Xylene and subsequent
Ethanol dehydration. Antigen retrieval was carried out by boiling slides in a solution
composed of Citiric Acid and Sodium Citrate. After 3 washes, 3 minutes each in IX
Phosphate-buffered saline (PBS), slides were placed in primary antibody overnight at 4
degrees Celsius (I: 1 00 dilution). Rabbit polyclonal antibodies used in staining included:
Anti-dimethyl-Histone H3 (Lys9) (Upstate #07-441), Anti-acetly-Histone H3 (Lys14)
(Upstate #07-353), and Anti-acetyl-H4 (Lys 12) (Upstate #07-595), all from Upstate Cell
Signaling Solutions. Slides were once again rinsed thrice in PHS and then placed in
secondary antibody (Goat anti-rabbit Alexaflour488; Molecular probes; 1 :2000) for 1-2
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hours at 37 degrees Celsius. Slides were rinsed in IX PHS 3 times, counterstained with
DAPI (1: 1 0,000), and mounted for microscope analysis.
Chromatin Immuno}2reci}2itation:
The genes that are verified will eventually be tested using chromatin
immunoprecipitation (ChIP). ChIP cross-links the transcription factor to the DNA, not
allowing it to disassociate. This will allow us to determine which genes are being
directly transcribed by transcription factor A-Myb, and which are not. The genes that are
not directly transcribed by A-Myb are probably regulated downstream by directly
affected genes.
This process will allow us to formulate a model of how A-Myb and the affected
genes are involved in spermatoegensis.
Results:
A-myb knockout mice exhibit impaired spennatogenesis n male mice and breast
duct epithelium differentiation problems in females (Toscani, 1997). Our mutation in this
gene, Repro9, produces mutants that do not exhibit the latter effect.
It is evident that Repro9 mutant testes are reduced in size when compared with
those of the normal male mouse. When sections were studied under the microscope, the
seminiferous tubules (ST) of adult wild-type testes have a much wider range of cells,
from spermatogonia to mature spenn, whereas mutant testes exhibit very few cells past
the pachytene stage of meiosis. This led us to believe that the probJem in these mutants
occurred between the diplotene and pachytene stages of meiosis. There are several
important checkpoints during the pachytene stage of meiosis, so this was not entirely
unexpected with a meiotic arrest mutant. Inside the nucleus of the wild type,
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chromosomes were fully paired. Mutant spemlatocytes exhibited regions of incomplete
synapsis and nonsynapsed chromosomes. The Repro9 mutation caused incomplete
synapsis to occur during meiosis.
Recombination mapping was used to narrow the critical region (the region that
contained the induced mutation) to proximal Chromosome 1 Most recently,
complementation anal.ysis performed between Repro9 and the targeted MybLI allele was
successful in showing that our mutation is, indeed, in the gene for A-Myb.
The affected MybLl gene encodes the 751 sa A-Myb transcription factor.
Sequencing showed that the Repro9 mutation causes an A213<E change in the amino
acid sequence. This change did not occur in the conserved DNA binding motif of the
transcription factor, yet it has profound effects on affected mice. As stated earlier, Myb
proteins work with cofactors, meaning that our mutation may be affecting A-Myb's
affinity for binding site or cofactors and thus leading to the observed phenotype. This
transcription activates other genes, some of which probably play an important role in
spermatogenesis and its checkpoints.
The microarray identified 208 differentially regulated genes in the 14d Repro9
mutant and 824 differentially regulated genes in the 7d Repro9 mutant. After narrowing
down the list of genes as discussed above, 38 genes remained. These genes are likely to
be directly or indirectly regulated by the A-Myb transcription factor. EaCh of the genes
was downregulated either in early-(l4dpp) or mid-pachytene (17dpp) testes, or both,
when compared with wild-type. A wide variety in the number of binding sites was found
in the selected genes. The following table summarizes these results:
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Table 2. Genes that are potentially affected by the mutation in A-Myb
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Analysis of the lkb upstream region of the chosen genes showed that genes with
Myb sites had a much greater frequency for the consensus equence about 200-300bp
upstream of +. , as should be expected for a binding site for a transcription factor.
Our real-time PCR results suggested that 7 of the primer sets that were used are
not optimal. Thus, these primers were re-designed using the same AlleleID software. All
7 of the new primer sets have been verified.
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The real-time PCR data thus far has verified the microarray data relatively well
(See Figure 2). This means that the genes that were thought to be affected by our
mutation are actually being affected. Verification of the expression of the other genes is
ongoing.
Histone Staining:
In staining Acetylated Lysine 12 of Histone 4 (21-day Sections), we found
staining of this marker in the spermatogonia of the wild-type, as expected, but not in the
mutant testes. In staining for Acetylated Histone 3 Lysl4 (21-day Sections), wild-type
stained in spermatocytes but did not stain in the mutant. The Dimethyl Lysine 9 of
in the same way (See Figure 3). This data must be further studied but it suggests that the
Repro9 mutation seems to be causing differential modifications in hisrones.
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Figure 3: Histone Immunostaining. Top to bottom: (a) Staining ofH4 Lys12 (21-day Sections),
(b) Staining of Acetylated H3 Lys14 (21-day Sections) (c) Staining ofH3 Dimethyl Lys 9 (21-
day Sections). Images were captured with 40X objective lens.
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Summary of Exnerimental Findin~s:
The Repro9 mutation results in male mice that are sterile and that have decreased
testis size. The sterility stems from problems in meiosis that trigger a meiotic checkpoint.
Thus, the seminiferous tubules of affected mice contained no cells past the pachytene
stage of meiosis. Complementation data shows that the Repro9 mutation affects the
MybLl gene and creates a modified A-Myb protein that is the cause of this phenotype.
As a transcription factor, A-Myb affects many genes within the testis, directly
affecting those genes that contain a Myb promoter and indirectly affecting downstream
genes. Microarray data showed 208 differentially regulated genes in 14d and 824 genes
in our 17d mutant, while real-time PCR verified that selected genes are indeed
differentially expressed in the Repro9 mutant.
Miehtv Mouse2:
The laboratory mouse has been the source of many recent breakthroughs in cancer
research, the discovery of stem cells, and insight into how cells differentiate 'self from
'non-self,' something that is crucial to solving the problem of rejection in organ
transplantation. "Mouse work has even begun to revolutionize basic Mendelian
assumptions, especially the assumption that a gene's expression is independent of the
parental origins of the chromosome" (Rader, 2004).
WhY the Mouse?
Human testing can be prohibitively expensive, unethical, or downright impossible. A
model organism that will be used to study human disease and physiology must be as
2 Thanks to Professor Judith Reppy for suggesting this title.
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similar as possible to the human while alleviating the problems that plague human
testing. The model organism must thus be much less expensive and much easier to work
with genetically than humans. In vitro cell culture systems are very powerful, but they
are too simple. With in vitro cultures, we cannot study physiological systems in their
entirety, and certainly not their interactions, which are many (paigen, 2003).
There is a reason that mice are so commonly used: they are simple to breed and make
great model organisms.
Mice are small, relatively tame animals, which makes them easy to handle, house,
and feed. They breed readily and often (several times per year), and three weeks after the
females have mated, good-sized litters of pups are born. which allows for a quick yield of
search results, whether in terms of providing a large sample or observing generational
patterns. Finally, mice are mammals with a 99 percent genetic homology to humans, and
they happen to get many of the same diseases as us (cancer, heart disease, etc.), which
(by extrapolation) makes it possible to track and experiment on many human health
conditions in situ. (Rader, 2004)
Because the mouse has served as a model organism for so long, there is a very
sophisticated genetic system with hundreds of inbred strains, even more mutants, a dense
genetic map, sophisticated mapping resources, and a well-established husbandry system
(paigen, 2003). The rewards from this are faster search results and greater consensus over
their meaning. Genetically standardized mice and rats now represent at least 70 percent
of all animals used in research.
According to Kenneth Paigen, the director of Jackson Laboratory in Bar Harbor,
Maine from 1989 to 2003, "more than 95 percent all mouse models in the world come
from JaCkson Laboratory." The 2001 lAX annual report concluded that "Researchers
around the world agree that JAX mice are the 'gold standard' of genetic purity in mouse
models" (Rader, 2004).
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It is common to hear of scientific breakthroughs arising from experiments in mice.
However, this was not always the case. Only in the twentieth century did the laboratory
mouse become an "iconic [symbol] of the value of standardization." (Rader, 2004)
The Mouse Becomes A Model Organism:
Before there was mouse research, there were breeders that bred the strangest mice
they could find. The furriest, most hairless, darkest, or any other variation of weird, was
treasured in these circles (Rader, 2004). These breeders were not breeding their mice for
any purpose other than for pleasure and profit, but their animals would eventually
become the basis for murine model organisms.
Interestingly enough, Gregor Mendel, the father of genetics, originally wanted to
study the inheritance of coat color in mice. The Bishop of Australia at the time did not
allow Mendel to carry out his tests using mice because the animals copulated.
Consequently, Mendel turned to peas to discover his laws (Paigen, 2003).
One man, a geneticist by the name of Clarence Cook Little, almost single-handedJy
made the mouse into what it is today. At Harvard's Bussey Institution, Little was put in
charge of tending a small colony of mouse mutants which was being used to study
Mendel's laws at the time. These mice were not ordinary mice, but rather mice obtained
from fancier organizations in Boston and beyond (Rader, 2004).
The public at this time was very resistant o animal testing, with many debates on the
ethics of testing on animals, specifically cats and dogs, which were of sentimental value.
Mouse fanciers provided scientists with both mice as a resource and a context in which
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mouse breeding was an accepted activity (Rader, 2004), It was partly for this reason that
murine research did not have as many hurdles as research on higher-order mammals.
'True' Strains:
In 1909, Ernest Tyzzer published a crucial paper on the inheritance of mice of
resistance to growth of transplanted tumors (paigen, 2003). In a climate of evolution,
genetics, and the validation of Mendel's laws in nearly every kind of plant and animal,
Little was sure that Tyzzer's results could be explained by Mendelian mechanisms, and
thus worked to develop the mice he tended as genetically stable research organisms
{Rader, 2004). Little was the first to construct an inbred mouse strain so that
reproducible genetic crosses would be possible. (paigen, 2003).
By the late 1910's, Little had articulated an ambitious vision for a scientific identity
of inbred mice as a means of true cooperation between medical and genetic research. As
he continued to breed 'true' strains of mice, he also defended his views on the mouse as a
model organism, both in research journals meant for the scientific community and in
popular magazines (Rader, 2004). At this stage, Little had laid the foundation for the
mouse as a research organism by inbreeding to create distinct genetic lines. He also
cemented the mouse as a model organism in the research community with his continuing
articles and research.
Standardized Protocols:
The research community had begun to look to the mouse as a model organism. The
next step was to standardize breeding and research protocols so that results could be more
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easily and definitively replicated. Little moved on to the Station for Experimental
Evolution (SEE) in Cold Spring Harbor, NY. There, he continued to breed his mice and
founded a group called the Mouse Club of America (MCA) that fonnalized the exchange
of material and practical infonnation about mouse breeding. Mouse researchers came to
SEE each swnmer to exchange breeding tips, information about mutant stocks, and
through periodicals throughout the year (Rader, 2004).
Many of the inbred mouse strains most commonly used today were bred within 20
years of Little's initial inbreeding efforts as a response to the need for genetically unifonn
stocks in the study of the cancer problem. In no other eukaryote is such a variety of
phenotypic diversity across the strains often exceeds that of the human population
single organism.
Mouse as a Model for Human Disease:
Little presented mice as models for cancer research during a time when more and
more were becoming concerned with this disease. In addition, shifts in the patronage of
American scientific work, away from small grants to individual researchers and towards
interest in Little's ideas and pushed Little to pursue finances to further his goals. In 1929,
with the financial backing of five wealthy Detroiters including Mr. Jackson, Little
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founded the Jackson Laboratory (JAX) in Bar Harbor, Maine, whose mice are now
considered the gold standard within the scientific community.
At the newly created Jackson Laboratory, Little continued to advance his
programmatic goals for mouse work so that he could increase "the recognition and
appreciation" of mouse work among medical men. Little strove to create an
interdisciplinary exchange among physicians, medical researchers, geneticists, public
health advocates, and social refonners (Rader, 2004). His reputation and visibility as a
cancer researcher continued to grow, and this afforded him many opportunities both to
finance lAX and to collaborate and spread his scientific ideas. Once again, Little spent
much of his time attempting to convince bOth the public and the scientific community of
the mouse's ability to model human disease.
Selling Mice:
The Jackson Laboratory opened its doors immediately after the stock market crashed,
and money was tight Little was eventually forced to mass produce and sell Jackson
Lab's mice to outside researchers in order to keep the institution alive (Rader, 2004).
Lab design and mouse breeding techniques were refined in order to create the best
product and to make as many mice as possible, as cheaply as possible; many of these
techniques are still being used today. This decision paved the way for the true
standardization and industrialization of the laboratory mouse. As a major center for
mouse breeding, lAX became a source for standardized research organisms for all mouse
researchers.
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Mouse breeding was one of the only sources of income for the Jackson Lab, and
Little worked hard to sell as many mice as he could to ke~ the laboratory afloat during
the depression. He looked for new markets for his mice and sought to expand the scope
of the laboratory mouse (Rader, 2004). As a result of Little's efforts, both researchers
and the public began to see the mouse as a model for all diseases, and not just as a model
for tumor research. Mice today are used to study all sorts of diseases, from cancer to
mental problems like autism, from stroke to heart disease.
George Snell helped push the standardization of mouse genetics by creating reading
materials. The publication of Biology of the Laboratory Mouse in 1938 was an important
milestone in mouse genetics. This book consolidated all established facts on the practice
of mouse work that crossed disciplinary boundaries and codified a body of universal
scientific knowledge that was once limited to lAX workers. The volume also
emphasized the JAX mouse as a gold standard (Rader, 2004). Snell also took over as
editor of The Mouse Newsletter, which became a centralized listing of all available mouse
mutants for genetic study.
Diseases Other Than Cancer:
The next evolution in mouse genetics was away from simple short-tenD mutational
effects and towards long-term studies. This occurred after the Second World War, when
the public became concerned about radioactive fallout s a result of the stories and images
that came out of Japan. Researchers began to use mice to study radiation's effects, both
in tenns of dominant and recessive mutations, and the mouse became even more suitable
for modeling human disease with this new use (Rader, 2004).
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The development of the transgenic mouse allowed for the expression of human and
other genes in the mouse. In a dramatic demonstration that captured the imagination of
both the lay public and scientists, Richard Palmiter and Ralph Brinster et. AI. fused the
rat growth hormone to a mouse promoter and inserted it as a transgene, obtaining very
2003). This was yet another example of public interest in mouse science.
The steady miniaturization of physiological measuring techniques and
introduction of imaging technologies (MRI, CT, PET, DEXA, etc.) are making it easier to
use mice and their genetic systems for phenotype exploration (paigen 2003). Human
diseases that were too difficult to observe in the past, such as asthma, inflammatory
bowel disease, Type n diabetes, and osteoporosis, can now be modeled in the mouse.
Our Lab's Role:
disease. C-Myb, the potential proto-oncogene, was originally studied because the entire
Myb family has very close relatives in humans (Gonda, 1982). The geDe we study also
has a human homolog and is thus applicable to humans. Any information we find about
the gene has a high probability of being relevant to humans, and can be used to develop
therapies for people and other animals which have homologs of MybLl
In fact, the MybLl knockout mouse that is currently ~ing used in our lab comes from
a different lab that was using this same mouse to study defects in breast duct epithelium.
While female Myb knockout mice have breast duct epithelium problems, affected males
are infertile. Our Repfo9 allele has male infertility only, suggesting "separate functions."
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Because the mouse IS such a standardized model organism, our lab was able to
request he knockout mouse and use it in our research. It is tedious and expensive to
create a knockout organism, and thus the ubiquity of the mouse as a model organism
helped to speed up our research. The availability of the MybLl knockout mouse made
both projects, as well as any future projects that may involve this gene, possible
This gene is not unique in its homology to humans. The high amount of overlap
between mouse and human genes, as discussed above, means that most human genes
have mousehomologs and can potentially be studied in mice. The more information we
gain from the laboratory mouse, the more socially acceptable and prominent mouse
research will become.
In publishing a paper about the mouse, we are reinforcing its use in scientific
research. The published material will reach scientists in related fields, and will show
them that mouse research is still very relevant to human disease (male sterility, in this
case). Electronic access of published papers has made them easier to distribute. Thus,
anyone who is interested in sterility or meiotic defects will be able to find our paper and
learn about ways in which mice can be used to study human disease.
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